Psoriasis
Current BC and Canadian guidelines, algorithms, tools, prescribing references and patient resources for nurse practitioners.
Reviewed by Joe Grafe Due
Review overdue
This page was due for review on November 6, 2027. Check the linked sources for newer versions before relying on it.
Key Sources¶
- Centre for Effective Practice - Psoriasis (2026) — Ontario primary care tool: assessment and diagnosis, including in skin of colour, and topical and systemic treatment options
- Canadian Family Physician - Diagnosis and Management of Psoriasis (2017) · PDF
International: DermNet - Psoriasis (2023)
International source: New Zealand clinical reference, not Canadian. Years are DermNet's last review dates.
- Psoriasis Treatment (2023)
- Types of psoriasis:
- Chronic plaque psoriasis (2023) · Images
- Guttate psoriasis (2023) · Images
- Scalp psoriasis (2023) · Images
- Nail psoriasis (2023) · Images
- Flexural psoriasis (2023) · Images
- Facial psoriasis (2023)
- Genital psoriasis (2023) · Images
- Palmoplantar psoriasis (2023) · Images
- Sebopsoriasis (2023)
- Oral psoriasis (2023)
- Erythrodermic psoriasis (2023)
- Generalised pustular psoriasis (2023)
- Pustular psoriasis of pregnancy (2023)
- Paediatric psoriasis (2023)
- Drug-induced psoriasis (2023)
- Related conditions, pregnancy and reproduction:
Further Resources¶
- Centre for Effective Practice - Psoriasis (2026) — Ontario primary care tool: assessment and diagnosis, including in skin of colour, and topical and systemic treatment options
Canadian consensus recommendations
International: NICE - Psoriasis: Assessment and Management, CG153 (2012, updated 2017)
International source: UK guidance, not Canadian. NICE last reviewed it in March 2025.
International: AAD-NPF Joint Guidelines of Care for Psoriasis (2019 to 2021)
International source: American guidance, not Canadian. American Academy of Dermatology and National Psoriasis Foundation, published in six parts in the Journal of the American Academy of Dermatology.
American Family Physician (AAFP, United States)
International source: American guidance, not Canadian.
- Psoriasis: Update on Topical Therapy From the American Academy of Dermatology (2022) — summary of the 2021 AAD-NPF topical guideline
Algorithms and Pathways¶
No BC or Alberta pathway for psoriasis found.
Assessment Tools and Calculators¶
- PharmaCare - Psoriasis Area and Severity Index (PASI) Worksheet (HLTH 5379) (2012) · PDF — the PASI worksheet used with PharmaCare Special Authority requests for targeted therapies
- PedsCases - Pediatric Psoriasis (2026) · PDF — one-page clinician infographic
- MDCalc - Psoriasis Area and Severity Index (PASI)
- DermNet - PASI (Psoriasis Area and Severity Index) (2023) · PO-PASI Scoring Tool — international (New Zealand)
- DermNet - Dermatology Life Quality Index (DLQI) (2024) — international (New Zealand)
Prescribing¶
- BC Immunization Manual, Part 2: Immunosuppressive Therapy (2026) · PDF
- Therapeutics Initiative - Calcipotriol/Betamethasone (Dovobet) Ointment for Psoriasis Vulgaris: Drug Assessment (2009) · Summary (2009) — BC systematic review
PharmaCare Special Authority: criteria and request forms
- Criteria for targeted therapies, requested by a dermatologist:
- Targeted Therapies for Plaque Psoriasis (HLTH 5380, rev. 2026/07/06) — the request form these criteria pages link to
- Criteria requested by a dermatologist or rheumatologist:
- Cyclosporine (2026) — palm and sole psoriasis criteria are for dermatologists only
- PharmaCare Special Authority Request (HLTH 5328, rev. 2019/09/30) — the form the cyclosporine criteria page links to
- RxFiles - Drug Comparison Charts: Topical Corticosteroids · PDF — potency classes compared; RxFiles has no psoriasis chart; the chart needs an RxFiles subscription
Ontario Drug Benefit - Exceptional Access Program (EAP) (2026)
Ontario coverage for drugs not on the ODB Formulary; nurse practitioners submit requests through SADIE
International: DermNet drug and treatment information for psoriasis
International source: New Zealand clinical reference, not Canadian. Check Canadian product availability and PharmaCare coverage. Years are DermNet's last review dates.
- Topical treatments:
- Phototherapy:
- Oral systemic treatments:
- Biologics:
Advice and Referral¶
- RACE - Rapid Access to Consultative Expertise — telephone and app advice from BC specialists for family physicians, nurse practitioners and midwives
- Pathways BC - Dermatology — login; specialists and clinics, with referral details
- Ontario eConsult (OTNhub) — specialist advice for Ontario physicians and nurse practitioners, usually without a patient referral
- RheumInfo - Comprehensive Arthritis Referral Tool (CART) — rheumatology referral triage form, for suspected psoriatic arthritis
Patient Resources¶
- HealthLink BC - Psoriasis
- HealthLink BC - Psoriasis: Skin, Scalp, and Nail Care
- HealthLink BC - Nail Psoriasis
- HealthLink BC - Phototherapy for Psoriasis
- HealthLink BC - Psoriatic Arthritis
- Canadian Dermatology Association - Psoriasis
- Arthritis Society Canada - Psoriatic Arthritis
- RheumInfo - Psoriatic Arthritis
- American Family Physician - Psoriasis Patient Handout (2023) — international (American)
Also known as: psoriasis, plaque psoriasis, guttate psoriasis, scalp psoriasis, nail psoriasis, inverse psoriasis, flexural psoriasis, pustular psoriasis, erythrodermic psoriasis, psoriatic arthritis, PsA, PASI, DLQI, calcipotriol, Dovobet, Enstilar, betamethasone, topical steroids, phototherapy, methotrexate, biologics, adalimumab, Humira, secukinumab, Cosentyx, ustekinumab, Stelara, apremilast, Otezla, tapinarof, deucravacitinib